Skip to Content
PODCAST
Partner Portal
Request a Proposal
Careers
Search
Search
Solutions
Neurology Center of Excellence
Phase Ib-III Trials
Rare Disease Center of Excellence
Safety and Pharmacovigilance Solutions
Decentralized and Virtual Solutions
Patient Engagement and Recruitment
Therapeutic Experience
Neurology Center of Excellence
Cell & Gene Therapy
Dermatology
Oncology
Nephrology
Pulmonology
Hematology
About Biorasi
Leadership & Scientific Advisors
Why Biorasi
Global Reach
Quality First
How We Partner
Resource Library
Contact Us
Solutions
Phase Ib-III Trials
Rare Disease Center of Excellence
Decentralized and virtual solutions
Patient Engagement and Recruitment
Therapeutic Experience
Neurology Center of Excellence
Cell & Gene Therapy
Dermatology
Oncology
Nephrology
Pulmonology
Hematology
About Biorasi
Leadership & Scientific Advisors
Why Biorasi
Global Reach
Quality First
How We Partner
Resource Library
Contact Us
PODCAST
Partner Portal
Request a Proposal
Careers
Resource • White Paper
Optimizing the Amount of Investigational Materials in ANDA Studies – Part Two
July 12th, 2017
|
ANDA
|
White Paper
For Dermal Semisolid Clinical Studies White Paper Series
Download White Paper
Get Access to this White Paper Now
Share this Story
Related Resources
White Paper
Patient Diversity in Clinical Research: Identifying Challenges, Opportunities, and Best Practices
White Paper
HEPATOCELLULAR CARCINOMA: Consider India for your next HCC international trial
View All
